Male Wi star rats were subjected to forebrain ischemia of lO min duration by clamping both common carotid arteries and simultaneously lowering systemic blood pressure to 40 mm Hg by exsanguination. Re covery was achieved by removing the arterial clamps and reinfusing the blood. Cortical levels of high-energy phos phates and glycolytic substrates were determined enzy matically. Naftidrofuryl (10 or 20 mg/kg i.p.) or ketamine (5 mg/kg i.v.) were applied 30 min prior to the induction of ischemia. S(-)-Emopamil (4 mg/kg) or nimodipine (50 fLg/kg) were administered by intravenous infusion over 30 min. Nimodipine and emopamil increased the blood glu cose level and lowered preischemic blood pressure. Under control conditions, a tendency toward a higher cortical glucose level was observed in treated brains. Brain energy stores were exhausted after ischemia in control and treated animals to the same degree. Lactate levels, however, were higher in emopamil-treated an imals. This effect was attributed to the elevated pre ischemic glucose levels. During the early recovery pe riod, the restoration of high-energy phosphates was ac-Abbreviations used: EEG, electroencephalogram; lAP, io doantipyrine; LCBF, local cerebral blood flow. 480 176 ± 49 376 ± 152" Habenula 219 ± 74 413 ± 146a Medial genic. body 258 ± 84 548 ± 167a Lateral genic. body 182 ± 44 306 ± 106a Hypothalamus 135 ± 33 266 ± 95a Hippocampus 166 ± 23 450 ± 175a Amygdala 113 ± 31 238 ± 129 Lateral septal nucleus 132 ± 29 220 ± 90 Nucleus accumbens 237 ± 82 350 ± 108 Nucleus caudatus 198 ± 60 278 ± 125 Globus pallidus 116 ± 21 185 ± 95 Subthalamic nucleus 248 ± 80 392 ± 141 Red nucleus 193 ± 26 455 ± 191a Substantia nigra 135 ± 41 388 ± 138b Superior colliculus 176 ± 27 454 ± 189b Inferior colliculus 365 ± 54 642 ± 8ge Lateral lemniscus 266 ± 35 545 ± 142e Pontine gray 145 ± 23 340 ± 150a Superior olivary nucleus 366 ± 148 676 ± 31e Cerebellar vermis 171 ± 37 357 ± 103b Cerebellar cortex 129 ± 17 219 ± 41b Dentate nucleus 264 ± 64 524 ± 160" Genu of corpus callosum 75 ± 27 104 ± 40 Corpus callosum 74 ± 16 112 ± 42 Internal capsule 78 ± 22 114 ± 36 Cerebellar white matter 66 ± 22 104 ± 19
A variety of the so-called cerebroprotective agents have been shown to ameliorate brain energy metabolism under hypoxic or ischemic conditions (Dirks et aI., 1984; Karcher et aI., 1984; Proctor et aI., 1984; Rachman et aI., 1984; Heffez and Passon neau, 1985; Krieglstein and Weber, 1986) . The ef fects include, among others, increases in the level celerated by both calcium entry blockers. Nimodipine and emopamil increased the levels of glucose and glu cose-6-phosphate in the early postischemic period. Nafti drofuryl (10 mg/kg) increased the level of creatine-phos phate and ATP after 2 min of recovery. Naftidrofuryl (20 mg/kg) exerted no effect on cerebral energy metabolism, but considerably reduced postischemic blood pressure (possibly thereby masking its ameliorative action). Keta mine accelerated the postischemic restoration of high-en ergy phosphates. In the conscious rat, local cerebral blood flow (LCBF) was determined with the 14C-iodoan tipyrine technique following emopamil (20 mg/kg s.c.) or naftidrofuryl (10 mg/kg i.v.) application. Both com pounds increased LCBF values in the majority of grey matter structures. It was concluded that the cerebropro tective agents investigated share an accelerating effect on the postischemic restoration of high-energy phosphates in cerebral cortex. Key Words: Cerebral blood flow Cerebroprotective agents-Energy metabolism-Isch emia-Rat brain.
of creatine-phosphate, ATP, glucose, and glucose-6-phosphate, as well as reduced ADP, AMP, and lactate levels. The interest mainly centers on the high-energy phosphates ATP and creatine-phos phate, as these substrates are essential for the maintenance of cellular function. A faster postisch emic restoration of these substrates, therefore, should improve the functional recovery of brain tissue. In the present study, compounds from dif ferent classes of drugs were investigated to eval uate whether or not they share common effects on postischemic brain energy metabolism. Calcium entry blockers have been demonstrated to ame liorate the resuscitation from ischemic insult in an-imal experiments, as well as in clinical studies (Steen et aI., 1983; Gelmers, 1984; Deshpande and Wieloch, 1985; Mohamed et aI. , 1985) . Effects on postischemic energy metabolism could be demon strated with several compounds of this class of drugs (P roctor et aI., 1984; Heffez and Passonneau, 1985; Weber and Krieglstein, 1985; Bielenberg et aI., 1986; Krieglstein and Weber, 1986) . Most of the effects hitherto observed have been demonstrated using the isolated perfused rat brain preparation. N aftidrofuryl has been demonstrated to protect brain energy stores from ischemia in the isolated rat brain as well (Stierstorfer and Krieglstein, 1986) . The role of central excitatory and inhibitory pathways in cytoprotection of the brain is well doc umented (Meldrum et aI., 1985; Wieloch et aI. , 1986) . The dissociative anesthetic ketamine is func tionally related to the N-methyl-D-aspartate (NMDA) receptor and inhibits the action of the ex citatory amino acids glutamate and aspartate (Col linridge, 1985) . Therefore, this compound was in cluded in the present investigation. Several alter ations in physiologic variables have been observed following the application of the compounds investi gated in the present study. These include the low ering of blood pressure and elevations in plasma glucose level (Mohamed et aI., 1984; Bielenberg et aI., 1986) . The dependence of postischemic energy metabolism on perfusion pressure or blood flow has been documented recently (Bielenberg et aI., 1986) . Therefore, cerebral blood flow determinations were performed after application of emopamil and nafti drofuryl. Alterations in blood glucose level have also been shown to greatly influence postischemic energy metabolism (Ljunggren et aI., 1974; Rehn crona et aI., 198 1) . It therefore seemed reasonable that energy metabolism might be influenced in vivo and in the isolated brain differently. By comparing the results obtained with the two different models, it should be possible to differentiate between pe ripheral and central drug actions.
MATERIALS AND METHODS

Animals
Male Wistar rats (lvanovas, Kisslegg, F. R.G.), weighing 200-350 g, were used in all experiments. They were maintained under controlled lighting and environ mental conditions (12-h dark/light cycle, 23 ± 1°C, 55 ± 5% relative humidity). The rats were kept on standard diet (Altromin, Lage, ER.G.) and tap water ad libitum until starting the experiment.
Materials
Emopamil [1,7 -bis-(phenyl)-3-aza-7-cyano-8-methyl nonane hydrochloride] was obtained from Knoll (Lud wigshafen, ER.G.), naftidrofuryl from Lipha (Essen, ER.G.), nimodipine from Bayer (Leverkusen, ER.G.), and ketamine from Parke-Davis (Freiburg, ER.G.). En zymes, coenzymes, and substrates were obtained from Boehringer (Mannheim, F. R.G.). DL-Dithiothreitol, HEPES [4-(2-hydroxyethyl)-piperazine-l-ethane sulfonic acid], imidazole, 2-mercaptoethanol, and I-thioglycerol were purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.). All other chemicals were of reagent grade.
Physiologic variables
Arterial Pcoz, Paz, pH (Corning 178; Corning Medical, Gie[3en, ER.G.) , blood pressure (Statham P23DB, Heto Rey, Puerto Rico; HSE-Elektromanometer, Hugstetten, ER.G.), and plasma glucose (Beckman Glucose Analyzer II; Munich, ER.G.) were checked routinely. Sample size for determination of blood gases or plasma glucose was 40 f.ll. Animals exhibiting values beyond the normal range were excluded from the experiments. In the conscious and the artificially ventilated rat, the variables were de termined 2 h and 30 min after the surgical procedure, re spectively, and again after drug or vehicle administration.
Surgical procedure and induction of ischemia
The surgical procedure and induction of ischemia was performed according to Smith et al. (1984) . Anesthesia was induced with 3.5% halothane, and the rats were con nected to a Starling type respirator, delivering 0.8% halo thane and 30% 0z in NzO. Muscle paralysis was main tained with 1 mg suxamethonium chloride i. v., repeated every 15-20 min. Polyethylene catheters were intro duced into the femoral artery and vein, and the common carotid arteries were isolated via a neck incision. A sili cone catheter was advanced into the inferior caval vein via the right jugular vein. A longitudinal skin incision was made over the skulI bone to accommodate electroenceph alogram (EEG) electrodes. The halothane was then dis continued, and the rat allowed a steady-state period of 30 min. Ischemia was induced by infusion of trimethaphan camphor sulfonate (5 mg/kg), carotid clamping, and cen tral venous exsanguination to a blood pressure of 40 mm Hg. Following 10 min of ischemia, blood pressure was restored by rapid reinfusion of the shed blood, and the carotid clasps were removed. Body temperature was held at about 37°C with a heating lamp throughout the experi mental procedure. The brains were chilled in liquid ni trogen according to Ponten et al. (1973) and stored at -80°C.
Enzymatic methods
Cerebral cortical tissue was removed from the frozen brain, weighed (250-350 mg), and extracted with 1.0 ml HC1-methanol (0.1 mollL HCI) and 4.0 ml (0.3 mollL) perchloric acid at -20°C. The following substrates were measured spectrophotometrically according to the proce dures described by Bergmeyer (1970) : Creatine-phos phate, ATP, ADP, AMP, glucose, pyruvate, and lactate. Glucose-6-phosphate and fructose-l ,6-bisphosphate were measured fluorimetrically (Folbergrova et aI., 1974) . The energy charge of the adenylate pool [EC = (ATP + 0.5 ADP)/(ATP + ADP + AMP)] was calculated according to Atkinson (1968) .
Surgical procedure for LCBF measurement
A small incision, 1 cm in length, was made in the groin; the femoral vessels were freed from surrounding tissue and polyethylene catheters (length 12 cm) filled with hep-arinized physiologic saline were inserted into the femoral artery and vein during 30-40 min of a light nitrous oxide/ halothane anesthesia [70:30 (vol/vol) nitrous oxide/ox ygen, 0.8-1% halothane]. The rats were injected with 1,000 U/kg heparin (Hoffmann-La Roche, Grenzach Wyhlen, ER.G.). After application of a local anaesthetic (xylocaine gel), the wound was closed. Animals were re strained by means of plaster of paris bandages covering hindlimbs and lower abdomen and then fixed on a prepa ration desk. In the harness, the rats could move their forequarters freely. The rats were allowed to recover for at least 2 h before any further experimental procedures were started. Body temperature was held close to 37°C with a heating lamp. Measurements of LCBF were started 20 min after application of emopamil and nafti drofuryl dissolved in physiologic saline, respectively.
Local cerebral blood flow
Determination of local cerebral blood flow was per formed by employing the 14C-iodoantipyrine (lAP) tech nique (Sakurada et aI., 1978) . In brief, 150 fLCi/kg lAP (specific activity 49.8-58.9 mCi/mmol) dissolved in 1 ml physiologic saline was infused into the femoral vein at progressively increasing rates with a peristaltic pump over 1 min. During infusion of the tracer, 15-20 timed arterial blood samples (10-15 fLl each) were collected from the free-flowing femoral arterial catheter in pre weighed counting vials. Flow rate of the arterial catheter was approximately 10-15 fLl/S. The scintillation vials were capped instantly to prevent evaporation and re weighed. Solubilization of blood samples was performed by adding 0.5 ml of a mixture of alkaline solubilizer (Lu masolve; Baker, Gror3-Gerau, ER.G.) and isopropanol (1:2 vol/vol). After 20 min of gentle agitation, the blood solution was bleached with 5 drops of hydrogen peroxide (30% wt/vol), and IS ml of a 9: I mixture of Lumagel (Baker, Gror3-Gerau, ER.G.) with 0.5 mol/L HCI was added. Liquid scintillation analysis was performed, with quenching being checked by adding an internal standard (LKB, Griifelfing, ER.G.). The rat was decapitated shortly before the end of infusion and the brain dissected out within 45-60 s and frozen in isopentane (-50°C).
The brain was sectioned in a cryostat at -20°C (Rei chert-Jung, model 2700, Nur3loch, ER.G); the 20-fLm slices were thaw-mounted on coverslips and dried on a hot plate at 50°C. Nissl staining was performed in addi tional slices for verification of brain structures. The cov erslips were glued to cardboard and, together with 14C_ methacrylate standards (Amersham-Buchler, Braunsch weig, F. R.G.), were exposed to Osray M3 film (Agfa-Gevaert, Leverkusen, ER.G.) for 10 days. The methacrylate standards had previously been calibrated against brain sections.
Densitometry of autoradiograms and calculation
Optical densities of the autoradiograms were measured with a computer-based transmission densitometer (DT 1505, Parry Instruments, Newbury, U.K.; Commodore 8032/8050, Commodore, Frankfurt, ER.G.). Each listed structure of the brain was measured 6 times in different brain sections, with the average value of the readings being stored on the floppy disk. Local blood flow values were computed from the concentration of the tracer in a defined brain region and the arterial plasma concentra tion curve of the tracer by taking into account corrections for the time lag and washout in the catheter (Reivich et aI., 1969) .
Drug administration
Naftidofuryl (10 or 20 mg/kg i.p.) or ketamine (5 mg/kg i. v.) was applied 30 min prior to the induction of isch emia. S(-)-Emopamil (4 mg/kg) or nimodipine (50 fLg/kg) was administered by intravenous infusion of I ml/kg sol vent over about 30 min. Both compounds were dissolved in 18% polyethyleneglycol (PEG 400) and 15% ethanol (95%) in distilled water. Controls received vehicle alone. Ischemia was induced 5 min after the end of infusion. In the conscious rat, emopamil (20 mg/kg) was applied sub cutaneously and naftidrofuryl (10 mg/kg) intravenously 15 min prior to LCBF determinations.
Statistics
In the LCBF series, statistical calculation was made by analysis of variance. The results concerning the series with the calcium entry blockers were evaluated statisti cally using analysis of variance and subsequent multiple t test, where appropriate. All other results were evaluated using Student's t test.
RESULTS
In the conscious rat, naftidrofuryl slightly re duced arterial blood pressure and heart rate (Table  1) . Emopamil in this series did not affect physio logic variables. Both emopamil and naftidrofuryl increased local cerebral blood flow in the majority of grey matter structures, whereas white matter structures were not affected (Tables 2 and 3 ).
In the experimental series concerning postisch emic energy metabolism, ketamine did not influ ence the measured physiologic variables (Table 4 ). With the lower dose of naftidrofuryl, alterations in physiologic variables could not be observed either. At a dose of 20 mg/kg, the drug considerably re duced the mean arterial blood pressure. The treated animals exhibited lower pressure values throughout the preischemic and the early postischemic period. At this dosage, the compound slightly decreased plasma glucose levels. The calcium entry blockers emopamil and nimodipine both led to a substantial decrease in blood pressure during drug infusion. After discontinuing the infusion, the pressure within a few minutes regained control level. Post ischemic blood pressure did not differ from the cor responding controls with either substance. Both calcium entry blockers increased the plasma glu cose level, with emopamil exhibiting a more pro nounced effect than nimodipine. This increase in plasma glucose was paralleled by a tendency toward higher levels in cortical glucose content in the preischemic period (Table 5 ). After 10 min of ischemia, the emopamil-treated animals exhibited slightly elevated lactate levels compared to controls. During the early recovery period, both calcium entry blockers elicited comparable effects on brain energy metabolism. Especially after 2 min of postischemic recirculation, the high-energy phosphates creatine-phosphate and ATP were con siderably higher in drug-treated animals, whereas ADP and AMP levels were lowered. Accordingly, Treatment groups: C, control; N, nimodipine; E, emopamil .
Values (except ratios) are means ± SD fr om 6-7 experiments expressed as f.\-mol/g cortical tissue. Different fr om control (t test): ap < 0.1; b p < 0.05; cp < 0.01; dp < 0.001. Energy charge of the adenylate pool = ATP + 0.5 ADP/ATP
the energy charge of the adenylate pool was ele vated in animals treated with either calcium entry blocker (Table 5 ; Fig. lA ). Both drugs led to an in crease in glucose-6-phosphate, and nimodipine in creased pyruvate levels. After 5 min of postisch emic recovery, ATP levels were still higher in drug treated animals than in controls, and both calcium entry blockers increased cortical glucose levels. This increase in glucose levels was also observed in the emopamil-treated group after 10 min of post ischemic recovery (Table 5) . Naftidrofuryl, at a dose of 10 mg/kg, caused an increase in creatine-phosphate and ATP after 2 min of recirculation (Table 6 ; Fig. lB) . The application of 20 mg/kg of this compound effected no metabolic alterations compared to control animals. Ketamine increased the levels of creatine-phosphate and ATP and simultaneously decreased ADP and AMP levels. Drug-treated animals exhibited an amelio rated energy charge at 2 min postischemia (Fig.  Ie) . After 20 min of recirculation, no metabolic changes were observed with naftidrofuryl or keta mine (Table 7) .
DISCUSSION
In the present study, some cerebroprotective agents were investigated to evaluate whether or not they share common effects on postischemic brain energy metabolism. All compounds tested pro duced higher values of creatine-phosphate and ATP in the early postischemic recovery. This acceler ated restoration of high-energy phosphates is con sistent with earlier findings obtained in the isolated perfused rat brain of improved postischemic energy stores with various cerebroprotective agents (Rachman et aI., 1984; Bielenberg et aI., 1986; Krieglstein and Weber, 1986; Stierstorfer and Krieglstein, 1986) , among them emopamil, nimodi pine, and naftidrofuryl. Effects of ketamine on the postischemic restoration of brain energy metabo lism have not yet been demonstrated.
The calcium entry blockers nimodipine and emo pamil increased plasma glucose levels, and this ef fect was accompanied by a tendency toward a higher cortical glucose content. These findings are in agreement with previous observations of an in creased plasma glucose level following nimodipine administration (Mohamed et aI., 1984) . Results in the isolated rat brain indicate that nimodipine in creases cerebral glucose content even at a constant glucose concentration in the perfusate (Weber, 1985) . As cerebral glucose levels depend on both plasma glucose level and on cerebral circulation (Bachelard et aI., 1972) , it may be suggested that the increased brain glucose content observed in the present study is at least partially due to the nimodi pine-induced increase in cerebral blood flow (Mo hamed et aI., 1984 (Mo hamed et aI., , 1985 . This view is corroborated by the fact that after nimodipine application, plasma glucose levels, however different from pre treatment, are not different from the corresponding vehicle-treated animals.
After 10 min of ischemia, lactate levels were higher in emopamil-treated animals than in con trols. As in a state of complete ischemia lactate levels greatly depend on preischemic glucose con tent (Ljunggren et aI., 1974) , the elevated lactate content may be traced back to the higher pre ischemic plasma and cortical glucose levels.
In the isolated perfused brain, emopamil reduced postischemic cortical lactate levels (Bielenberg et aI., 1986) . In the present study, cortical lactate levels in emopamil-treated animals were not dif ferent from controls during postischemic recovery. This discrepancy may be explained by the fact that after 10 min of ischemia, cortical lactate levels were higher in emopamil-treated rats. As this difference vanished during postischemic recovery, it seems likely that emopamil also enhanced the rate of lac tate degradation under in vivo conditions. During the early recovery period, the calcium entry blockers accelerated the restitution of high-energy phosphates and, hence, the adenylate energy charge. Apart from the two introduced in the present study, several other calcium entry blockers, such as flunarizine, diltiazem, and gallopamil, ame liorated the postischemic restitution of brain energy metabolism (Krieglstein and Weber, 1986) . The levels of glucose and glucose-6-phosphate also were higher in drug-treated tissue. These results arc in line with observations in the isolated per fused rat brain demonstrating increased postisch emic glucose and glucose-6-phosphate levels with several calcium entry blockers (Weber, 1985; Bie lenberg et aI., 1986) .
The result of an increase in blood flow by emo pamil is consistent with previous investigations evaluating cerebral circulatory effects of different calcium entry blockers (Haws et aI., 1983; Mo hamed et aI., 1984 Mo hamed et aI., , 1985 Beck, 1985) , showing a similar pattern of altered intracerebral flow. The unchanged flow values in white matter structures may be related to capillary density, which is about 5 times lower in white than in grey matter (Rapoport, 1985) .
The role of postischemic flow rate on the restora tion of brain energy metabolism has been demon strated recently (Bielenberg et aI., 1986) . In that study, the faster replenishment of brain energy stores by emopamil has been attributed to its vaso dilating properties. The present result of an in creased cerebral blood flow following emopamil ad ministration is in support of this concept. In the isolated brain preparation, emopamil caused a slight increase in preischemic flow rate and an even stronger increase during early reperfusion (Bielen berg et aI., 1986) . Similar results were obtained with a variety of calcium entry blockers (Weber, 1985) . It therefore seems likely that under the con ditions employed in the present study, postischemic blood flow is also enhanced by emopamil. The lower dose of naftidrofuryl significantly in creased postischemic creatine-phosphate and ATP levels. Several authors have reported changes in brain energy metabolism following naftidrofuryl ad ministration under control conditions (Meynaud et aI., 1975) , during ischemia (Meynaud et aI., 1975) , and during or after hypoxia (Wyllie et aI., 1981) . Effects on postischemic energy metabolism have been demonstrated recently after short -term expo sure of the isolated perfused rat brain to global ischemia (Stierstorfer and Krieglstein, 1986) . In that study, energy stores were not completely ex hausted during the ischemic period. Therefore, the results on postischemic energy metabolism are not comparable to the effects observed in the present investigation. N aftidrofuryl predominantl y pre served brain energy metabolism probably by re ducing energy demands. Lowered energy require ments may also have contributed to the improved postischemic energy state observed in the present study. The fact that reduced energy demands can cause an accelerated restitution of high-energy phosphates has been demonstrated for methohex ital (Dirks et aI., 1984) .
Conflicting reports exist about the effects of naf tidrofuryl on cerebral blood flow. Increases (Cos nier et ai., 1977; Levy and Wallace, 1977) in cere bral blood flow as well as unchanged or even de creased flows (James et aI., 1978; Heiss, 1981) have been observed. In the isolated rat brain, naftidro fury I reduced global perfusion rate during the pre ischemic period, whereas postischemic flow rate was considerably higher in the drug-treated group (Stierstorfer and Krieglstein, 1986) . Therefore, the effect of naftidrofuryl on LCBF was reevaluated. It seems likely that the increased cerebral blood flow observed in the present study is not limited to con trol conditions, but is maintained during postisch emic recovery. This view is confirmed by observa tions of improved regional circulation in stroke pa tients after naftidrofuryl application (Kobayashi et aI., 1984) . Therefore, both a reduced energy de mand and an increased cerebral blood flow may be considered as causal factors leading to an acceler ated restoration of high-energy phosphates.
At a dose of 20 mg/kg, postischemic energy me tabolism was not improved by naftidrofuryl. How ever, this dosage substantially reduced preischemic blood pressure. The postischemic pressure restitu tion was also delayed. It is easily conceivable that this slowed pressure increase can cause a delayed recirculation. As discussed above, replenishing of energy stores greatly depends on flow rate. There fore, the missing action of the higher dose of nafti drofuryl, suggests that effects of higher doses are counteracted by the concomitant systemic hypo tension. Both calcium entry blockers investigated also reduced arterial blood pressure. This effect, however, in contrast to naftidrofuryl, was limited to the preischemic period and could not be observed during recovery. The metabolic effects of these compounds, therefore, seem not to be superim posed by systemic cardiovascular drug actions.
Ketamine has been reported to alter cerebral blood flow only by increasing carbon dioxide ten sion (Schwedler et aI., 1982) . However, if Paco2 was maintained constant, as performed in our ex periments, ketamine failed to cause any significant change in CBF. The drug at the same dosage as in the present study significantly reduced CMR02. Therefore, reduced energy requirements rather than vascular effects seem to be causally involved in the action of ketamine on postischemic energy metabolism.
In summary, the cerebroprotective agents emo pamil, nimodipine, naftidrofuryl, and ketamine led to a faster restitution of brain energy metabolism after ischemia. Emopamil and naftidrofuryl in creased local cerebral blood flow in the conscious rat. The metabolic actions of the calcium entry blockers are paralleled by their vascular effects, whereas the metabolic effects exerted by naftidro furyl are discussed with respect to both its vascular action and a reduced energy demand. The effects of ketamine are related to lower energy demands. Comparing the results in vivo and in the isolated perfused rat brain reveals a potent tool in differen tiating between peripheral and central drug actions.
